This HTML5 document contains 44 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
dctermshttp://purl.org/dc/terms/
n9http://linked.opendata.cz/resource/domain/vavai/projekt/
n7http://linked.opendata.cz/resource/domain/vavai/riv/tvurce/
n18http://linked.opendata.cz/resource/domain/vavai/subjekt/
n17http://linked.opendata.cz/ontology/domain/vavai/
shttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
n3http://linked.opendata.cz/ontology/domain/vavai/riv/
n15http://linked.opendata.cz/resource/domain/vavai/vysledek/RIV%2F00209805%3A_____%2F13%3A%230000443%21RIV14-MZ0-00209805/
n2http://linked.opendata.cz/resource/domain/vavai/vysledek/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n14http://linked.opendata.cz/ontology/domain/vavai/riv/klicoveSlovo/
n19http://linked.opendata.cz/ontology/domain/vavai/riv/duvernostUdaju/
xsdhhttp://www.w3.org/2001/XMLSchema#
n16http://linked.opendata.cz/ontology/domain/vavai/riv/aktivita/
n13http://linked.opendata.cz/ontology/domain/vavai/riv/jazykVysledku/
n11http://linked.opendata.cz/ontology/domain/vavai/riv/druhVysledku/
n4http://linked.opendata.cz/ontology/domain/vavai/riv/obor/
n8http://reference.data.gov.uk/id/gregorian-year/

Statements

Subject Item
n2:RIV%2F00209805%3A_____%2F13%3A%230000443%21RIV14-MZ0-00209805
rdf:type
skos:Concept n17:Vysledek
rdfs:seeAlso
http://www.mzm.cz/fileadmin/user_upload/publikace/casopisy/fm_49_2_2013/fm-2-2013-abstract-06.pdf
dcterms:description
Dendritic cell-based anticancer vaccination is a newly studied and developed approach in cancer immunotherapy based on the stimulation of immune system and supporting natural resistance to cancer via tumor-specific antigens. Cancer immunotherapy is less damaging to the rest of the body in contrast to chemo- or radio-therapy, therefore cancer therapeutic vaccines are not associated with any serious side effects. Dendritic-cell based anticancer vaccinations are used these days as a supporting treatment (in clinical trials) after surgical tumor removal. Their crucial effects seem to be in the prevention of relapse and extended remission period or patients’ survival via generation of specific immune response able to clear and/or suppress any residual cancer cells. Dendritic cell-based anticancer vaccination is a newly studied and developed approach in cancer immunotherapy based on the stimulation of immune system and supporting natural resistance to cancer via tumor-specific antigens. Cancer immunotherapy is less damaging to the rest of the body in contrast to chemo- or radio-therapy, therefore cancer therapeutic vaccines are not associated with any serious side effects. Dendritic-cell based anticancer vaccinations are used these days as a supporting treatment (in clinical trials) after surgical tumor removal. Their crucial effects seem to be in the prevention of relapse and extended remission period or patients’ survival via generation of specific immune response able to clear and/or suppress any residual cancer cells.
dcterms:title
Dendritic cell-based anticancer vaccination in immunotherapy of metastatic renal carcinoma Dendritic cell-based anticancer vaccination in immunotherapy of metastatic renal carcinoma
skos:prefLabel
Dendritic cell-based anticancer vaccination in immunotherapy of metastatic renal carcinoma Dendritic cell-based anticancer vaccination in immunotherapy of metastatic renal carcinoma
skos:notation
RIV/00209805:_____/13:#0000443!RIV14-MZ0-00209805
n17:predkladatel
n18:ico%3A00209805
n3:aktivita
n16:P n16:I
n3:aktivity
I, P(ED2.1.00/03.0101), P(NT11137)
n3:cisloPeriodika
2
n3:dodaniDat
n8:2014
n3:domaciTvurceVysledku
n7:1895214 n7:2486725 n7:9637419
n3:druhVysledku
n11:J
n3:duvernostUdaju
n19:S
n3:entitaPredkladatele
n15:predkladatel
n3:idSjednocenehoVysledku
68360
n3:idVysledku
RIV/00209805:_____/13:#0000443
n3:jazykVysledku
n13:eng
n3:klicovaSlova
renal carcinoma; dendritic cells; cancer immunotherapy
n3:klicoveSlovo
n14:cancer%20immunotherapy n14:dendritic%20cells n14:renal%20carcinoma
n3:kodStatuVydavatele
CZ - Česká republika
n3:kontrolniKodProRIV
[F6EBFEBE8172]
n3:nazevZdroje
Folia Mendeliana
n3:obor
n4:FD
n3:pocetDomacichTvurcuVysledku
3
n3:pocetTvurcuVysledku
4
n3:projekt
n9:NT11137 n9:ED2.1.00%2F03.0101
n3:rokUplatneniVysledku
n8:2013
n3:svazekPeriodika
49
n3:tvurceVysledku
Valík, Dalibor Matoulková, Eva Vojtěšek, Bořivoj
s:issn
0085-0748
s:numberOfPages
4